Abstract Context Prostate cancer (PCa) patients found to have adverse pathologic features
following radical prostatectomy (RP) are less likely to be cured with surgery alone. Objective …

Context Salvage radiotherapy (SRT) is a standard of care for men who recur
postprostatectomy, and recent randomized trials have assessed the benefit and toxicity of …

The management of patients with biochemical, local, nodal, or oligometastatic relapsed
prostate cancer has become more challenging and controversial. Novel imaging modalities …

Up to 50% of patients treated with radical surgery for localized prostate cancer may
experience biochemical recurrence that requires appropriate management. Definitions of …

Radical radiotherapy for prostate cancer offers excellent long-term outcomes for patients
with high-risk disease. The increased risk of pelvic nodal involvement in this cohort has led …

Background Outcomes with postprostatectomy salvage radiation therapy (SRT) are not
ideal. Little evidence exists regarding potential benefits of adding whole pelvic radiation …

Purpose To evaluate the patterns of relapse and impact on the intended treatment when
using 68 Ga-prostate-specific membrane antigen (PSMA) ligand positron emission …

Background The optimal prostate-specific antigen (PSA) level after radical prostatectomy
(RP) for defining biochemical recurrence and initiating salvage radiation therapy (SRT) is …

INTRODUCTION Although salvage radiotherapy (SRT) for PSA recurrence after radical
prostatectomy provides better oncological outcomes when delivered early, in the absence of …

Purpose The role of elective pelvic nodal irradiation in salvage radiotherapy (sRT) remains
controversial. Utilizing 18 F-DCFPyL PET/CT, this study aimed to investigate differences in …